RxDoctor Payments Data

Alan Schob, MD

Interventional Cardiology · Miami, FLNPI 1205843547

Payments from drug & device makers

$2,788in general payments, 2019–2025

Across 36 payments — averaging $77.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$1K
  • Abbott$924
  • Edwards Lifesciences$271
  • Cardiva Medical, Inc.$93
  • Alnylam Pharmaceuticals Inc.$89
  • Inari Medical, Inc.$71

What the payments were for

  • Travel & lodging$62022%
  • Food & beverage$2,16878%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,788 in reported general payments places this provider in the 20th percentile of 623 interventional cardiology providers in Florida.

See all interventional cardiology providers in Florida

Medicare billing

Part B allowed, 2024
$5,009
Medicare patients
27
Services billed
28

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ezetimibe24$1,677
Valsartan11$718
Rosuvastatin Calcium36$580
Atorvastatin Calcium24$270
Metoprolol Succinate17$251
Losartan Potassium17$157
Amlodipine Besylate19$148
Carvedilol11$62

Paid to pharmacies, not to this prescriber.

Other interventional cardiology in Miami

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →